Serial #79239066
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79239066 Trademark

Serial Number: 79239066 • Registration: 5876245

Serial #79239066 is a trademark filed by Sichuan Jishengtang Pharmaceutical Co.,Ltd. on May 22, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sichuan Jishengtang Pharmaceutical Co.,Ltd.

North Fanjiang Road,

Entity Type: 99

Trademark Details

Filing Date

May 22, 2018

Registration Date

October 8, 2019

Published for Opposition

July 23, 2019

Cancellation Date

April 24, 2026

Goods & Services

Chinese medicine nostrum in the nature of traditional Chinese medicines for treating influenza, depression, cough, diabetes, hypertension, respiratory diseases, cardiovascular disease, intestinal disorders, gastrointestinal diseases, hyperlipidemia, and hypercholesterolemia; medicines for human purposes, namely, medicines for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; chemico-pharmaceutical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; pharmaceutical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; active ingredient, namely, dietary fiber for use in the manufacture of pharmaceuticals for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; biochemical drugs for treating cancer and eye diseases; chemical preparations for pharmaceutical purposes, namely, chemical preparations for treating hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; nutritive substances for microorganisms for medical purposes

Filing History

CANCELLED SECTION 71
Apr 24, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 8, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 13, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 4, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 4, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 8, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Aug 2, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 17, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 17, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2019 NONP
ASSIGNED TO LIE
Jun 19, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 29, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 13, 2019 GNFN
FINAL REFUSAL E-MAILED
Apr 13, 2019 GNFR
FINAL REFUSAL WRITTEN
Apr 13, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2019 TROA
REFUSAL PROCESSED BY IB
Oct 13, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 21, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 21, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 18, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 17, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 28, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 23, 2018 REPR